脂肪蛋白 (a) 和急性心肌梗塞后的长期复发性心脏病发作
Gema Miñana1, Alberto Cordero2, Lorenzo Fácila3
1Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de Valencia, INCLIVA, Valencia, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Madrid, Spain; Universitat de Valencia, Valencia, Spain.
The American journal of cardiology
|October 20, 2023
概括
由于急性心肌梗塞 (AMI) 住院的患者中脂蛋白a (Lp[a]) 水平升高,预测长期复发性AMI的风险更高. 这一发现凸显了Lp[a]作为AMI幸存者的风险分层的关键标志物.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 心血管疾病 心血管疾病
背景情况:
- 脂蛋白 (Lp[a]) 是发生性缺血性心脏病的确立危险因素.
- 对于急性心肌梗塞 (AMI) 的住院幸存者,特别是长期复发性AMI的风险分层中Lp[a]的作用不太清楚.
研究的目的:
- 调查Lp[a]水平与初始AMI事件后非常长期的复发性AMI风险之间的关联.
- 在长期随访队列中评估Lp[a]作为复发性心肌梗塞的预测因素.
主要方法:
- 对2000年10月至2003年6月期间连续出院的1,223名AMI患者的回顾性分析.
- 在指数住院期间测量了Lp[a]水平.
- 负二项回归被用来评估Lp[a]在出院和总复发性AMI之间的关系,平均随访时间为9.9年.
主要成果:
- Lp[a]水平与长期全因死亡率的增加无关 (p=0.934).
- 在Lp[a]水平和总长期再发作的风险之间发现了显著的正面和非线性关联 (p=0.016).
- 在流行次组中没有观察到Lp[a]的差异效应.
结论:
- 在AMI住院期间测量的升高的Lp[a]水平与长期出现复发性心肌梗塞的风险增加有关.
- Lp[a]可以作为一种有价值的生物标志物,用于识别 AMI 幸存者在未来再次发病的高风险.
- 需要进一步的前性研究来证实这些发现并探索临床影响.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
676
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
676
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Inflammation
53.7K
Overview
53.7K
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
19
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
19


